Abstract 【Objective】Objective To investigate the clinicopathological characteristics and related risk factors in middle-aged and elderly patients with breast hyperplasia. 【Methods】 The clinical data of 139 middle-aged and elderly patients with breast hyperplasia admitted to Ningshan County Hospital from April 2017 to April 2020 (observation group) were retrospectively analyzed, and the clinical data of 139 healthy female volunteers in the same period (control group) were selected. The basic data [age, body mass index (BMI), residential area, nationality, marital status, wearing time, tightness, sleeping time, nursing method, breast stopping method, eating habits] of the two groups after admission were collected. The pathological characteristics of patients with breast hyperplasia were analyzed. Logistic regression analysis was used to analyze the risk factors of breast hyperplasia in the middle-aged and elderly. 【Results】The pathological features of middle aged and elderly patients with hyperplasia of mammary glands were duct epithelial hyperplasia, cyst formation, lobular hyperplasia, apocrine metaplasia, fibroadenoma formation and atypical hyperplasia. The proportion of patients with age ≥ 65 years, BMI ≥ 25 kg/m2, wearing time of tattooed chest ≥ 8 h, wearing tight tattooed chest, sleeping time<5 h, non breast feeding and drug breast stopping in the observation group was higher than that in the control group, and the difference was statistically significant (P<0.05). Logistic regression analysis showed that age ≥ 65 years, BMI ≥ 25 kg/m2, wearing time of tattooed chest ≥ 8 hours, wearing tight tattooed chest, sleeping time<5 hours, non breast feeding, and drug breast stopping were the risk factors for adenosis in the middle-aged and elderly (P<0.05). 【Conclusion】 The occurrence of mammary hyperplasia in middle-aged and elderly patients is affected by many factors, including age, BMI, wearing time of tattooed chest, tightness of tattooed chest, sleeping time, lactation mode, and breast stopping mode. Clinicians should pay attention to the above factors in the diagnosis and treatment of such patients.
SHEN Gui-hu,HU Yong-xin. Analysis of Clinicopathological Characteristics and Related Risk Factors in Middle-aged and Elderly Patients with Breast Hyperplasia[J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(11): 1634-1636.
[1] 王斐,申朔豪,刘丽媛,等.不同年龄段女性乳腺增生症临床病理特征分析[J].中华普通外科杂志,2019,34(3):235-239. [2] 贾宁.2015年重庆地区8814例女性职工乳腺疾病检出结果分析[J].安徽医药,2018,22(8):1484-1486. [3] 中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学.乳腺增生症诊治专家共识[J].中国实用外科杂志,2016,36(7):759-762. [4] GILLETT C E,LEE A H,MILLIS R R,et al.Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia.[J].J Pathol,2015,184(4):396-400. [5] 秦福才,谢永高,李银珍.乳腺癌早期危险因素分析及高频超声的应用价值[J].中国妇幼保健,2018,33(15):3542-3545. [6] SHAFRIR A L,RICE M S,GUPTA M,et al.The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status[J].Gynecol Oncol,2016,143(3):628-635. [7] 杜二球,高霞,尚丽,等.抗苗勒管激素联合基础FSH及FSH/LH对生育高龄女性卵巢功能储备的评估[J].西部医学,2018,30(5):701-703. [8] 邵婷,陶芳标,陶慧慧,等.母亲孕前BMI和孕期增重对学龄前儿童超重肥胖的影响[J].中华预防医学杂志,2016,50(2):123-127. [9] 左婷婷.体重正常、超重和肥胖女性中乳腺癌亚型分布情况[J].中华预防医学杂志,2017,51(5):408. [10] 张岸辉,谌永毅,刘翔宇.乳腺癌化疗患者睡眠障碍研究进展[J].中华现代护理杂志,2015,21(28):3461-3463. [11] 唐倩,邓华聪.睡眠时间与胰岛素抵抗的关系及其可能机制研究进展[J].实用医院临床杂志,2015,12(3):198-201. [12] 李斌,廖秋月,王兆芬,等.中国女性乳腺增生危险因素Meta分析[J].中国健康教育,2016,32(5):443-446.
2022, Vol. 39 
